Human Brain Studies May Soon Extend Donated Brain Life to Two Weeks
Extending the Window for Neural Observation
Connecticut-based biotech firm Bexorg secured a significant grant from the Advanced Research Projects Agency for Health. The award totals up to $28.3 million to expand its research capabilities. The goal is to keep donated human brains alive for fourteen days. Currently, the company’s platform sustains brain tissue for only twenty-four hours. This new funding will allow scientists to observe longer-term neural activity. The initiative marks a major step forward in understanding complex brain functions. It provides a critical window for studying neurological diseases and cognitive processes in living tissue.
The current twenty-four-hour limit restricts what researchers can learn about brain health. Many biological processes unfold over days or weeks, not just hours. By extending viability to two weeks, Bexorg aims to capture these slower mechanisms. This extension allows for detailed analysis of how neurons communicate and degrade. It offers a more realistic model for testing potential therapies. Researchers can monitor changes in real-time without relying on animal models. The technology keeps brain cells functioning in a controlled environment. This approach reduces the need for invasive animal testing while providing human-specific data. The grant supports the development of infrastructure needed to maintain this extended lifespan. It ensures that the biological integrity of the tissue remains intact throughout the study period.
Why Does This Change Matter for Medicine?
This advancement could transform how we understand neurological conditions. Diseases like Alzheimer’s and Parkinson’s develop slowly over years. Short observation periods often miss key stages of disease progression. A two-week window provides sufficient time to see early signs of decline. It also allows for the evaluation of drug responses over a meaningful timeframe. Scientists can test how different compounds affect brain function without immediate cell death. This method bridges the gap between simple lab cultures and full human trials. It accelerates the discovery of treatments for complex disorders. The ability to study live human tissue for extended durations opens new avenues for personalized medicine.
How much funding did Bexorg receive? Bexorg was awarded up to $28.3 million by the Advanced Research Projects Agency for Health. This grant supports the expansion of their brain preservation platform from one day to two weeks.
Frequently Asked Questions
What is the current limitation of the technology? The existing platform currently keeps donated human brains viable for only twenty-four hours. This short duration limits the scope of biological observations and therapeutic testing that researchers can perform.
Who is providing the financial support? The Advanced Research Projects Agency for Health, known as ARPA-H, provided the funding. This agency focuses on advancing health technologies through high-risk, high-reward research projects.